Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

Ascelia Pharma - Filing #701899

Concept	2021-01-01 to 2021-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2020-01-01 to 2020-12-31	As at 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31	2020-01-01 to 2020-12-31
Disclosure of effect of changes in foreign exchange rates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Reserve of exchange differences on translation	—	254,000 SEK	—	—	—	—	—	—	—	119,000 SEK	—	—	—	—	—	—
Disclosure of information when currency is not exchangeable into another currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets	—	58 882 SEK	—	—	—	—	—	—	—	59 050 SEK	—	—	—	—	—	—
Current assets	—	274 611 SEK	—	—	—	—	—	—	—	196 324 SEK	—	—	—	—	—	—
Non-current liabilities	—	553,000 SEK	—	—	—	—	—	—	—	956,000 SEK	—	—	—	—	—	—
Current liabilities	—	25 106 SEK	—	—	—	—	—	—	—	18 362 SEK	—	—	—	—	—	—
Revenue	—	—	—	—	—	—	- SEK	—	—	—	- SEK	—	—	—	—	—
Profit (loss)	- SEK	—	- SEK	- SEK	125 903 SEK	- SEK	125 903 SEK	125 903 SEK	98 697 SEK	—	98 697 SEK	- SEK	- SEK	- SEK	98 697 SEK	- SEK
Other comprehensive income	—	—	—	—	—	—	135,000 SEK	—	—	—	5,000 SEK	—	—	—	—	—
Comprehensive income	– SEK	—	– SEK	135,000 SEK	125 768 SEK	– SEK	125 768 SEK	125 903 SEK	98 697 SEK	—	98 702 SEK	– SEK	5,000 SEK	– SEK	98 702 SEK	– SEK